Sabra Health Care REIT (SBRA) Stock Forecast, Price Target & Predictions
SBRA Stock Forecast
Sabra Health Care REIT stock forecast is as follows: an average price target of $17.29 (represents a -5.98% downside from SBRA’s last price of $18.39) and a rating consensus of 'Hold', based on 9 wall street analysts offering a 1-year stock forecast.
SBRA Price Target
The average price target for Sabra Health Care REIT (SBRA) is $17.29 based on 1-year price targets from 9 Wall Street analysts in the past 3 months, with a price target range of $20.00 to $13.00. This represents a potential -5.98% downside from SBRA's last price of $18.39.
SBRA Analyst Ratings
According to 9 Wall Street analysts, Sabra Health Care REIT's rating consensus is 'Hold'. The analyst rating breakdown for SBRA stock is 0 'Strong Buy' (0.00%), 4 'Buy' (44.44%), 5 'Hold' (55.56%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Sabra Health Care REIT Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Sep 12, 2024 | Nicholas Joseph | Citigroup | $20.00 | $18.35 | 8.99% | 8.75% |
| Sep 03, 2024 | Michael Lewis | Truist Financial | $18.00 | $17.00 | 5.88% | -2.12% |
| Jun 21, 2024 | David Rodgers | Robert W. Baird | $16.00 | $14.55 | 9.97% | -13.00% |
| May 15, 2024 | Nicholas Yulico | Scotiabank | $15.00 | $14.67 | 2.25% | -18.43% |
| May 31, 2023 | Omotayo Okusanya | Credit Suisse | $13.00 | $10.68 | 21.72% | -29.31% |
| Dec 27, 2021 | Michael R Lewis | Truist Financial | $16.00 | $13.10 | 22.14% | -13.00% |
| Aug 24, 2021 | Jonathan Petersen | Jefferies | $19.00 | $15.35 | 23.78% | 3.32% |
| May 04, 2021 | Daniel Bernstein | Capital One Financial | $20.00 | $16.43 | 21.73% | 8.75% |
The latest Sabra Health Care REIT stock forecast, released on Sep 12, 2024 by Nicholas Joseph from Citigroup, set a price target of $20.00, which represents a 8.99% increase from the stock price at the time of the forecast ($18.35), and a 8.75% increase from SBRA last price ($18.39).
Sabra Health Care REIT Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 4 |
| Avg Price Target | - | $19.00 | $17.25 |
| Last Closing Price | $18.39 | $18.39 | $18.39 |
| Upside/Downside | -100.00% | 3.32% | -6.20% |
In the current month, the average price target of Sabra Health Care REIT stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Sabra Health Care REIT's last price of $18.39. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 11, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Sep 12, 2024 | Citigroup | Neutral | Buy | Upgrade |
| Aug 26, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Aug 23, 2024 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
| May 21, 2024 | Citigroup | Neutral | Neutral | Hold |
| May 15, 2024 | Scotiabank | Sector Perform | Sector Perform | Hold |
| Oct 10, 2023 | Bank of America Securities | Neutral | Buy | Upgrade |
| Sep 20, 2023 | Jefferies | - | Buy | Upgrade |
| Aug 11, 2023 | Bank of America Securities | - | Neutral | Upgrade |
| May 31, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Sabra Health Care REIT's last stock rating was published by Scotiabank on Oct 11, 2024. The company gave SBRA a "Sector Perform" rating, the same as its previous rate.
Sabra Health Care REIT Financial Forecast
Sabra Health Care REIT Revenue Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $163.40M | $161.63M | $161.17M | $161.32M | $164.99M | $140.76M | $155.96M | $163.10M | $135.66M | $128.59M | $152.93M | $152.37M | $152.05M | $143.25M | $153.92M | $149.35M | $155.76M | $149.83M |
| Avg Forecast | $201.30M | $198.90M | $195.60M | $193.10M | $186.24M | $184.13M | $181.46M | $178.96M | $176.30M | $172.67M | $166.54M | $160.40M | $162.91M | $160.30M | $158.72M | $159.13M | $154.07M | $154.30M | $156.07M | $153.02M | $150.10M | $151.57M | $152.94M | $149.87M | $152.20M | $151.16M | $145.92M | $153.14M | $148.89M | $113.34M |
| High Forecast | $209.00M | $206.50M | $203.08M | $200.48M | $193.36M | $191.17M | $188.40M | $182.05M | $179.87M | $173.99M | $166.54M | $160.40M | $166.04M | $160.30M | $164.79M | $165.21M | $159.96M | $154.30M | $156.07M | $153.02M | $150.10M | $151.57M | $152.94M | $149.87M | $152.20M | $151.16M | $145.92M | $153.14M | $148.89M | $113.34M |
| Low Forecast | $192.08M | $189.79M | $186.64M | $184.25M | $177.71M | $175.70M | $173.15M | $173.97M | $169.95M | $171.36M | $166.54M | $160.40M | $160.82M | $160.30M | $151.45M | $151.84M | $147.01M | $154.30M | $156.07M | $153.02M | $150.10M | $151.57M | $152.94M | $149.87M | $152.20M | $151.16M | $145.92M | $153.14M | $148.89M | $113.34M |
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 1.01% | 1.02% | 1.01% | 1.07% | 0.91% | 1.00% | 1.07% | 0.90% | 0.85% | 1.00% | 1.02% | 1.00% | 0.95% | 1.05% | 0.98% | 1.05% | 1.32% |
Sabra Health Care REIT's average Quarter revenue forecast for Mar 24 based on 4 analysts is $160.40M, with a low forecast of $160.40M, and a high forecast of $160.40M. SBRA's average Quarter revenue forecast represents a -1.83% decrease compared to the company's last Quarter revenue of $163.40M (Dec 23).
Sabra Health Care REIT EBITDA Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $59.54M | $103.30M | $101.82M | $102.73M | $21.87M | $86.09M | $104.01M | $111.39M | $46.93M | $79.60M | $-63.29M | $102.97M | $105.17M | $105.44M | $99.55M | $106.13M | $111.21M | $94.85M |
| Avg Forecast | $117.81M | $116.41M | $114.48M | $113.01M | $109.00M | $107.77M | $106.20M | $104.74M | $103.18M | $101.06M | $97.47M | $98.10M | $95.34M | $93.82M | $92.89M | $89.18M | $129.43M | $92.03M | $93.08M | $81.07M | $89.52M | $90.40M | $91.22M | $109.02M | $90.77M | $90.16M | $87.03M | $126.35M | $88.80M | $67.60M |
| High Forecast | $122.32M | $120.86M | $118.85M | $117.33M | $113.17M | $111.88M | $110.26M | $106.55M | $105.27M | $101.83M | $97.47M | $117.72M | $97.18M | $93.82M | $96.45M | $107.02M | $155.32M | $92.03M | $93.08M | $97.29M | $89.52M | $90.40M | $91.22M | $130.83M | $90.77M | $90.16M | $87.03M | $151.62M | $88.80M | $67.60M |
| Low Forecast | $112.41M | $111.07M | $109.23M | $107.83M | $104.00M | $102.83M | $101.34M | $101.81M | $99.46M | $100.29M | $97.47M | $78.48M | $94.12M | $93.82M | $88.64M | $71.35M | $103.55M | $92.03M | $93.08M | $64.86M | $89.52M | $90.40M | $91.22M | $87.22M | $90.77M | $90.16M | $87.03M | $101.08M | $88.80M | $67.60M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.62% | 1.10% | 1.10% | 1.15% | 0.17% | 0.94% | 1.12% | 1.37% | 0.52% | 0.88% | -0.69% | 0.94% | 1.16% | 1.17% | 1.14% | 0.84% | 1.25% | 1.40% |
4 analysts predict SBRA's average Quarter EBITDA for Mar 24 to be $98.10M, with a high of $117.72M and a low of $78.48M. This is 64.77% upper than Sabra Health Care REIT's previous annual EBITDA (Dec 23) of $59.54M.
Sabra Health Care REIT Net Income Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $17.16M | $-15.10M | $21.19M | $-9.49M | $-84.95M | $-50.06M | $16.80M | $40.60M | $-24.35M | $10.22M | $-132.57M | $33.45M | $37.12M | $36.46M | $29.62M | $35.22M | $39.74M | $23.28M |
| Avg Forecast | $40.30M | $40.30M | $40.30M | $40.30M | $41.09M | $41.88M | $40.30M | $39.51M | $38.40M | $37.14M | $35.30M | $46.24M | $31.89M | $30.82M | $22.12M | $42.04M | $-67.16M | $38.18M | $36.93M | $38.21M | $31.26M | $32.33M | $36.00M | $35.41M | $43.24M | $41.61M | $34.48M | $41.92M | $45.58M | $39.35M |
| High Forecast | $42.30M | $42.30M | $42.30M | $42.30M | $43.13M | $43.96M | $42.30M | $41.47M | $40.53M | $37.69M | $35.31M | $55.49M | $32.83M | $32.35M | $23.22M | $50.44M | $-53.73M | $38.18M | $36.93M | $45.86M | $31.26M | $32.33M | $36.00M | $42.50M | $43.24M | $41.61M | $34.48M | $50.31M | $45.58M | $39.35M |
| Low Forecast | $37.90M | $37.90M | $37.90M | $37.90M | $38.64M | $39.38M | $37.90M | $38.44M | $37.33M | $36.59M | $35.29M | $36.99M | $30.95M | $28.98M | $20.81M | $33.63M | $-80.59M | $38.18M | $36.93M | $30.57M | $31.26M | $32.33M | $36.00M | $28.33M | $43.24M | $41.61M | $34.48M | $33.54M | $45.58M | $39.35M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.54% | -0.49% | 0.96% | -0.23% | 1.26% | -1.31% | 0.46% | 1.06% | -0.78% | 0.32% | -3.68% | 0.94% | 0.86% | 0.88% | 0.86% | 0.84% | 0.87% | 0.59% |
Sabra Health Care REIT's average Quarter net income forecast for Mar 24 is $46.24M, with a range of $36.99M to $55.49M. SBRA's average Quarter net income forecast represents a 169.52% increase compared to the company's last Quarter net income of $17.16M (Dec 23).
Sabra Health Care REIT SG&A Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $16.68M | $10.76M | $9.53M | $10.50M | $10.85M | $9.68M | $8.65M | $10.40M | $8.24M | $8.68M | $8.81M | $8.94M | $8.11M | $7.22M | $8.67M | $8.76M | $5.51M | $8.71M |
| Avg Forecast | $11.97M | $11.83M | $11.63M | $11.48M | $11.08M | $10.95M | $10.79M | $10.64M | $10.48M | $10.27M | $9.90M | $11.84M | $9.69M | $9.53M | $9.44M | $10.76M | $22.72M | $9.18M | $9.28M | $9.78M | $8.93M | $9.01M | $9.10M | $9.46M | $9.05M | $8.99M | $8.68M | $63.80M | $8.85M | $6.74M |
| High Forecast | $12.43M | $12.28M | $12.08M | $11.92M | $11.50M | $11.37M | $11.20M | $10.83M | $10.70M | $10.35M | $9.90M | $14.21M | $9.87M | $9.53M | $9.80M | $12.92M | $27.26M | $9.18M | $9.28M | $11.74M | $8.93M | $9.01M | $9.10M | $11.36M | $9.05M | $8.99M | $8.68M | $76.57M | $8.85M | $6.74M |
| Low Forecast | $11.42M | $11.29M | $11.10M | $10.96M | $10.57M | $10.45M | $10.30M | $10.35M | $10.11M | $10.19M | $9.90M | $9.47M | $9.56M | $9.53M | $9.01M | $8.61M | $18.17M | $9.18M | $9.28M | $7.83M | $8.93M | $9.01M | $9.10M | $7.57M | $9.05M | $8.99M | $8.68M | $51.04M | $8.85M | $6.74M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.72% | 1.13% | 1.01% | 0.98% | 0.48% | 1.05% | 0.93% | 1.06% | 0.92% | 0.96% | 0.97% | 0.94% | 0.90% | 0.80% | 1.00% | 0.14% | 0.62% | 1.29% |
Sabra Health Care REIT's average Quarter SG&A projection for Mar 24 is $11.84M, based on 4 Wall Street analysts, with a range of $9.47M to $14.21M. The forecast indicates a -29.02% fall compared to SBRA last annual SG&A of $16.68M (Dec 23).
Sabra Health Care REIT EPS Forecast
| Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 4 | 6 | 3 | 5 | 4 | 8 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 5 | 4 | 5 | 4 | 5 | 4 | 5 | 4 | 4 | 3 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $-0.07 | $0.09 | $-0.04 | $-0.37 | $-0.22 | $0.07 | $0.18 | $-0.11 | $0.05 | $-0.61 | $0.16 | $0.18 | $0.18 | $0.14 | $0.17 | $0.20 | $0.12 |
| Avg Forecast | $0.17 | $0.17 | $0.17 | $0.17 | $0.17 | $0.18 | $0.17 | $0.17 | $0.16 | $0.16 | $0.15 | $0.14 | $0.13 | $0.13 | $0.09 | $0.12 | $0.13 | $0.16 | $0.16 | $0.15 | $0.13 | $0.14 | $0.15 | $0.17 | $0.18 | $0.18 | $0.15 | $0.20 | $0.20 | $0.17 |
| High Forecast | $0.18 | $0.18 | $0.18 | $0.18 | $0.18 | $0.19 | $0.18 | $0.17 | $0.17 | $0.16 | $0.15 | $0.14 | $0.14 | $0.14 | $0.10 | $0.12 | $0.13 | $0.16 | $0.16 | $0.15 | $0.13 | $0.14 | $0.15 | $0.17 | $0.18 | $0.18 | $0.15 | $0.20 | $0.20 | $0.17 |
| Low Forecast | $0.16 | $0.16 | $0.16 | $0.16 | $0.16 | $0.17 | $0.16 | $0.16 | $0.16 | $0.15 | $0.15 | $0.14 | $0.13 | $0.12 | $0.09 | $0.11 | $0.12 | $0.16 | $0.16 | $0.15 | $0.13 | $0.14 | $0.15 | $0.17 | $0.18 | $0.18 | $0.15 | $0.20 | $0.20 | $0.17 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.00% | -0.50% | 0.96% | -0.36% | -2.89% | -1.35% | 0.44% | 1.18% | -0.82% | 0.36% | -3.96% | 0.93% | 0.97% | 1.01% | 0.95% | 0.84% | 1.03% | 0.71% |
According to 4 Wall Street analysts, Sabra Health Care REIT's projected average Quarter EPS for Mar 24 is $0.14, with a low estimate of $0.14 and a high estimate of $0.14. This represents a 138280.00% increase compared to SBRA previous annual EPS of - (Dec 23).
Sabra Health Care REIT Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| MPW | Medical Properties Trust | $4.26 | $11.33 | 165.96% | Hold |
| GMRE | Global Medical REIT | $8.64 | $11.75 | 36.00% | Buy |
| CHCT | Community Healthcare Trust | $18.39 | $22.33 | 21.42% | Buy |
| HR | Healthcare Realty Trust | $17.56 | $19.00 | 8.20% | Buy |
| LTC | LTC Properties | $38.37 | $38.25 | -0.31% | Hold |
| SBRA | Sabra Health Care REIT | $18.39 | $17.29 | -5.98% | Hold |
| NHI | National Health Investors | $77.14 | $72.20 | -6.40% | Hold |
| CTRE | CareTrust REIT | $30.66 | $25.50 | -16.83% | Buy |
| WELL | Welltower | $137.40 | $95.67 | -30.37% | Buy |